Actively Recruiting
Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19
Led by Gaffree & Guinle Universitary Hospital · Updated on 2024-05-21
30
Participants Needed
1
Research Sites
133 weeks
Total Duration
On this page
Sponsors
G
Gaffree & Guinle Universitary Hospital
Lead Sponsor
R
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Collaborating Sponsor
AI-Summary
What this Trial Is About
On January 30, 2020, the WHO (World Health Organization) declared the new coronavirus pandemic as the sixth public health emergency of international concern. In February 2020, the virus was designated by the Coronavirus Study Group of the International Committee on Virus Taxonomy as severe acute respiratory syndrome coronavirus 2. Many reports have described the appearance of olfactory or gustatory dysfunction simultaneously with other pre-established symptoms of COVID-19. Symptoms such as loss of taste or smell may appear 2 to 14 days after being infected with COVID-19. Worldwide, evidence regarding anosmia (loss of smell) and dysgeusia (change in taste) has been associated with COVID-19 infection. OBJECTIVES: To evaluate the effectiveness of low-intensity laser in treating changes in smell and taste after COVID-19 infection and map which changes obtained the best results. MATERIAL AND METHODS: This is an intervention study whose sample will consist of 30 individuals with loss of smell and taste for more than 6 months after COVID-19 infection, aged 18 years or older.
CONDITIONS
Official Title
Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have experienced loss of smell and taste for more than 6 months after COVID-19 infection
- Age 18 years or older
- Confirmed COVID-19 infection by PCR test
You will not qualify if you...
- Presence of comorbidities before COVID-19 that affect smell and taste
- History of head and neck cancer
- Epilepsy diagnosis
- Mouth breathing habit
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
university hospital Gafree Guinle
Rio de Janeiro, Brazil, 20270004
Actively Recruiting
Research Team
D
DEBORAH S SALES, phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here